Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 49NIH 3INDUSTRY 3NETWORK 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1Endocrine 1

Conditions

Thyroid Nodule 1Sarcoma, Endometrial Stromal 1Prostatic Neoplasms 1Adrenocortical Adenoma 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × INDUSTRY × High-Energy Shock Waves × Clear all
NCT01013025 2024-01-02

Vantas Implant Retrieval Study

Endo Pharmaceuticals

Completed
12 enrolled
Genitourinary

Prostatic Neoplasms

NCT02150213 2016-12-05

Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492

Novartis

Phase 2 Completed
59 enrolled 6 charts
EndocrineGynecologicSarcoma

Sarcoma, Endometrial Stromal, Adrenocortical Adenoma

NCT00858104 2014-05-26

Percutaneous Laser Ablation in Benign Thyroid Nodules.Long Term Results

Elesta S.R.L.

Phase 4 Completed
200 enrolled
Head & Neck

Thyroid Nodule

Data powered by HemOnc (CC BY 4.0) Colophon âš¡